Lymphokine-Activated Killer Activity in Women with Endometriosis

Didier J. Oosterlynck, D J Oosterlynck, F A Lacquet, F. Lacquet, Mark Waer, M Waer, Philippe R. Koninckx, P R Koninckx
Gynecologic and obstetric investigation · 2010 · vol. 37(3) , pp. 185–190 · doi:10.1159/000292556 · PMID:8005550 · W2093674908
article OA: closed CC0 ⤵ 16 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

Women with endometriosis showed decreased peripheral blood NK cell activity, but this was corrected with IL-2 stimulation in vitro, which also enhanced cytotoxicity against endometrial cells.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The aim of the present study was to investigate whether women with endometriosis displayed a decreased lymphokine-activated killer (LAK) activity. In 15 women with and 7 women without endometriosis the cytotoxicity against four different tumor cell lines – K562, the endometrium carcinomas AN3CA and RL95, the natural-killer (NK)-resistant Daudi cell line – was investigated, using either freshly isolated peripheral blood mononuclear cells (PBMC) or recombinant interleukin (IL)-2-stimulated PBMC. In 5 additional women collagenase-DNase-digested endometrium was used, to investigate whether recombinant IL-2-activated lymphocytes displayed an increased cytotoxicity against fresh and cultured endometrial cells. The cytotoxicity of unstimulated PBMC toward K562, AN3CA and RL95 target cells was decreased in women with endometriosis compared to women without endometriosis (p < 0.05, for all). After recombinant IL-2 stimulation the cytotoxicity toward the four different target cells increased significantly, both in women with and without endometriosis. There was no difference in LAK-mediated cytotoxicity against the four tumoral cells between women with and without endometriosis. Significant LAK activity was demonstrated against both fresh and cultured (72 h) endometrial cells. The cytotoxicity of autologous lymphocytes against cultured endometrial cells was 31.0+ 17 versus 67.4 ± 5.8%, using lymphocytes cultured in medium without and with recombinant IL-2, respectively (paired t test, p < 0.02). These results demonstrated that the decreased NK activity in peripheral blood of women with endometriosis was corrected after in vitro recombinant IL-2 stimulation of lymphocytes. Furthermore, this study showed that cytotoxicity toward fresh and cultured endometrial cells increased after in vitro incubation of PBMC with recombinant IL-2.

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Endometriosis Interleukin-2 Killer Cells, Lymphokine-Activated Adult Cells, Cultured Collagenases Collagenases Cytotoxicity, Immunologic Deoxyribonucleases Deoxyribonucleases Endometrial Neoplasms Endometrial Neoplasms Endometriosis Endometrium Endometrium Female Flow Cytometry Humans Interleukin-2 Killer Cells, Lymphokine-Activated

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (16)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:11:29.222973+00:00
License: CC0 · commercial use OK